Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP for Vascular Ulcers
NCT02213952Phase 3Withdrawn
- Sponsor
- Osakidetza
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma in venous ulcer (2 arms), sponsored by Osakidetza. Primary endpoint: Ulcer size change at 9 weeks. Planned start Jan 2015; status: withdrawn.
02
Drugs
platelet-rich plasma
03
Conditions
venous ulcer
Beyond the preview
Go deeper on NCT02213952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213952.